Department of Health and Social Care
Faster access to cannabis-based medicines as import restrictions are changed
Patients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.
Import restrictions have been changed to help ensure people with prescriptions for cannabis-based products for medicinal use do not have their treatment delayed or interrupted.
The changes will help patients with conditions such as rare, serious forms of epilepsy or multiple sclerosis.
Licensed wholesalers will now be able to:
- import larger quantities of cannabis-based products
- hold supplies for future use by patients with prescriptions
Most cannabis-based medicines are imported from foreign countries. Export restrictions mean it can take weeks or months for the drugs to reach the patients in the UK. For example, in Canada, an export certificate can take 4 to 8 weeks.
In addition, safeguards against addiction and the misuse of drugs mean that patients with prescriptions for unlicensed medicines, such as medicinal cannabis, need to have their prescription reviewed every 30 days by specialist doctors. This can lead to delays in treatment if there are also delays to imports.
The new measures will be implemented by the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) from 2 March.
It follows the law change in October 2018 to allow specialist doctors to prescribe cannabis-based products for medicinal use where clinically appropriate in the UK.
The government is working with industry to explore further ways to reduce costs and encourage more research into uninterrupted access to cannabis-based medicinal products where clinically appropriate.
The government will also continue to engage with medical associations and patients to build evidence, using trials in the UK to accelerate our understanding of how medicinal cannabis can benefit patients. This is necessary for wider prescribing by NHS clinicians in future.
In November last year, the National Institute for Health and Care Excellence (NICE) recommended 2 cannabis-based medicinal products for patients with multiple sclerosis and hard-to-treat epilepsies.
The Department of Health and Social Care continues to work closely with NHS England-NHS Improvement (NHSE-I) and the National Institute of Health Research (NIHR) to establish clinical trials to develop the evidence-base to support further commissioning decisions.
Health and Social Care Secretary Matt Hancock yesterday said:
Every time I meet the families of young people dealing so bravely with childhood epilepsy, I am reminded of just how much they have been through.
The changes made today are a tremendous step towards improving the supply of cannabis-based medicinal products by helping to ensure quicker and more reliable access for patients.
But we still have a long way to go. We need more research into the quality and safety of these medicines, and to do all we can to cut down the costs and remove barriers so that, when appropriate, patients can access it, including on the NHS.
Home Secretary Priti Patel yesterday said:
I have taken swift action to allow specialist doctors to issue prescriptions for cannabis-based medicinal products, when they consider their patients would benefit from this treatment.
This will allow patients and their families with challenging conditions to access them more easily, when appropriate, to ensure they can be treated in days, not months.
Latest News from
Department of Health and Social Care
New study into COVID-19 vaccine dose interval for pregnant women03/08/2021 14:20:00
Extensive real-world data shows vaccines are safe and highly effective for pregnant women.
NHS COVID-19 app updated to notify fewer contacts to isolate03/08/2021 10:10:10
Public urged to continue using NHS COVID-19 app as changes made will result in fewer close contacts being advised to self-isolate.
More than 85 million COVID-19 vaccines administered in UK02/08/2021 16:10:00
Over 88% of adults have had a first dose and over 72% of adults have had both doses.
Uber, Bolt and Deliveroo help drive vaccine uptake02/08/2021 10:10:10
Leading businesses to offer incentives for people to get COVID-19 jabs.
Presidential visit strengthens healthcare partnership with Kenya30/07/2021 14:20:00
The healthcare partnership between Kenya and the UK government has been strengthened through the signing of a Memorandum of Understanding (MoU)
UK travel update: government waives quarantine for arrivals fully vaccinated from Europe and USA while also confirming international cruise restart28/07/2021 16:07:00
The latest steps towards reopening international travel make it easier for people vaccinated in Europe or the USA to travel to England.
UK begins donating millions of COVID-19 vaccines overseas28/07/2021 12:27:00
Foreign Secretary announces the UK will begin to deliver 9 million COVID-19 vaccines around the world to help tackle the pandemic.
Action to tackle misery of drug misuse28/07/2021 11:27:00
The government has appointed Dame Carol Black as an independent advisor on drug misuse and will publish an ambitious new drug strategy later this year.